{
    "organizations": [],
    "uuid": "7af5cca10daca92c14d53b85fe3165df6b054ad9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-feb-22-idUSL8N1QB5EH",
    "ord_in_thread": 0,
    "title": "Swiss stocks - Factors to watch on Feb 22",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ZURICH, Feb 22 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday:\nCOMPANY STATEMENTS * Cembra Money Bank said its net income rose 1 percent to 144.5 million Swiss francs in 2017. It proposed to increase its dividend to 3.55 francs per share.\n* Partners Group sait it raised a total of 3 billion euros for its latest direct private infrastructure offering.\n* Santhera Pharmaceuticals said it increased its share capital to pay the upfront consideration for the license to develop and commercialize a clinical stage candidate for pulmonary diseases obtained from Polyphor.\nECONOMY * Swiss industrial orders for Q4 are due at 0815 GMT.\nReporting by Zurich newsroom\n ",
    "published": "2018-02-22T14:16:00.000+02:00",
    "crawled": "2018-02-23T15:40:12.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "zurich",
        "feb",
        "reuters",
        "main",
        "factor",
        "may",
        "affect",
        "swiss",
        "stock",
        "thursday",
        "company",
        "statement",
        "cembra",
        "money",
        "bank",
        "said",
        "net",
        "income",
        "rose",
        "percent",
        "million",
        "swiss",
        "franc",
        "proposed",
        "increase",
        "dividend",
        "franc",
        "per",
        "share",
        "partner",
        "group",
        "sait",
        "raised",
        "total",
        "billion",
        "euro",
        "latest",
        "direct",
        "private",
        "infrastructure",
        "offering",
        "santhera",
        "pharmaceutical",
        "said",
        "increased",
        "share",
        "capital",
        "pay",
        "upfront",
        "consideration",
        "license",
        "develop",
        "commercialize",
        "clinical",
        "stage",
        "candidate",
        "pulmonary",
        "disease",
        "obtained",
        "polyphor",
        "economy",
        "swiss",
        "industrial",
        "order",
        "q4",
        "due",
        "gmt",
        "reporting",
        "zurich",
        "newsroom"
    ]
}